CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, and Family Medicine Specialists (FMS), a ...

CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, and Family Medicine Specialists (FMS), ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch ...

"We view this as a critical step toward expanding timely access and improving care for Medicare patients," said Meesha Dogan, PhD., CEO and co-founder of Cardio Diagnostics. "Many Medicare ...

CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD™, an ...

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, is ending the year on a strong note, announcing the Centers for Medicare and Medicaid Services ...

A study by Emory cardiovascular researchers has paved the way for the development of a new cardiovascular reactivity risk score that could better identify and improve how quickly high-risk patients ...

Researchers used advanced machine learning to increase the accuracy of a national cardiovascular risk calculator while preserving its interpretability and original risk associations. Risk calculators ...

CHICAGO, July 08, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), a precision cardiovascular medicine company with a pioneering technology at the intersection of epigenetics ...